US BROKER MOVES: MSFT upgraded at Sitfel; ALV downgraded at Wolfe Research

Daily broker roundups of this kind are mostly routine housekeeping, and the established pattern is that single-name rating changes move the target stock briefly and fade unless they cluster.

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

BCB Director David says the neutral rate was probably higher at a given point

Iranian President will likely talk about the Minab school attack at his UN General Assembly speech

US BROKER MOVES: MSFT upgraded at Sitfel; ALV downgraded at Wolfe Research

Norway's Industry and Commerce Minister says Norway plans to to mine Europe's largest rare earth deposit by 2028, AFP reports

US Pre-Market Movers: SOXX, MSFT, BABA, FUN, KBH, GIS, MPC, GEHC, IMVT, PAYX, CTAS

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

UPGRADES

  • Editas Medicine (EDIT) upgraded from Neutral to Buy at Guggenheim; PT USD 5.00
  • Graphic Packaging Holding (GPK) upgraded from Neutral to Overweight at JPMorgan; PT USD 11.50 (prev. USD 12.50)
  • Microsoft (MSFT) upgraded from Hold to Buy at Stifel; PT USD 575.00 (prev. USD 530.00)
  • RXO (RXO) upgraded from Negative to Neutral at Susquehanna

DOWNGRADES

  • Autoliv (ALV) downgraded from Outperform to Peerperform at Wolfe Research
  • ARC Resources (ARX) downgraded from Market Perform to Underperform at Raymond James
  • CBIZ (CBZ) downgraded from Outperform to Market Perform at William Blair
  • Realty Income (O) downgraded from Sector Outperform to Sector Perform at Scotiabank; PT USD 59.00 (prev. USD 67.00)

INITIATIONS

  • Amneal Pharmaceuticals (AMRX) initiated Outperform at Oppenheimer; PT USD 27.00
  • ANI Pharmaceuticals (ANIP) initiated Perform at Oppenheimer; PT USD 85.00
  • Amphenol (APH) initiated Outperform at Bernstein SocGen Group; PT USD 99.00
  • Applied Digital (APLD) initiated Buy at UBS; PT USD 38.00
  • Axsome Therapeutics (AXSM) initiated Buy at Truist Securities; PT USD 285.00
  • Beta Bionics (BBNX) initiated Overweight at Wells Fargo; PT USD 28.00
  • Belden (BDC) initiated Buy at Needham; PT USD 140.00
  • Cipher Mining (CIFR) initiated Buy at UBS; PT USD 23.00
  • Collegium Pharmaceutical (COLL) initiated Outperform at Oppenheimer; PT USD 50.00
  • Core Scientific (CORZ) initiated Buy at UBS; PT USD 24.00
  • CorMedix (CRMD) initiated Outperform at Oppenheimer; PT USD 15.00
  • HubSpot (HUBS) initiated Sector Perform at FBN Securities; PT USD 230.00
  • Hut 8 (HUT) initiated Buy at UBS; PT USD 143.00
  • Innoviva (INVA) initiated Outperform at Oppenheimer; PT USD 35.00
  • Maze Therapeutics (MAZE) initiated Outperformer at CIBC; PT USD 50.00
  • Madrigal Pharmaceuticals (MDGL) initiated Buy at Citi; PT USD 725.00
  • Oric Pharmaceuticals (ORIC) initiated Buy at BTIG; PT USD 26.00
  • Pacira BioSciences (PCRX) initiated Outperform at Oppenheimer; PT USD 32.00
  • Pulse Biosciences (PLSE) initiated Buy at BTIG; PT USD 70.00
  • TE Connectivity (TEL) initiated Outperform at Bernstein SocGen Group; PT USD 243.00
  • Teva Pharmaceutical Industries (TEVA) initiated Outperform at Oppenheimer; PT USD 50.00
  • Toro (TTC) initiated Outperform at Oppenheimer; PT USD 120.00
  • Vanda Pharmaceuticals (VNDA) initiated Outperform at Oppenheimer; PT USD 10.00
  • Viatris (VTRS) initiated Outperform at Oppenheimer; PT USD 25.00
  • TeraWulf (WULF) initiated Buy at UBS; PT USD 24.00
  • Wave Life Sciences (WVE) initiated Neutral at JPMorgan
Context

The items that historically carry signal are the outliers: a Hold-to-Buy move on a mega-cap with a raised target, as with Microsoft here, is rarer than the small-cap churn and tends to reflect a thesis change rather than model maintenance, and an upgrade paired with a lowered price target, as with Graphic Packaging, reads as a valuation reset rather than fresh conviction. The initiations skew heavily toward two pockets, specialty and generic pharmaceuticals from one shop and bitcoin miners and digital infrastructure from another, and coverage launches in waves from a single desk have tended to mark a house view on a subsector rather than stock-specific calls, with the cluster itself the tell. The Autoliv downgrade to peer perform fits the pattern of autos-supplier caution that has recurred when production forecasts soften. Follow-ons worth noting are whether peers in the initiated groups catch sympathy moves and whether the Microsoft call is echoed by other houses in coming sessions.

Related headlines

The whole workspace, free to try.

Try it free